Hooman Yarmohammadi, MD
Surgery · Philadelphia, PANPI 1295933885
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $23,152 of the $36,572 with a category attached, or 63.3%. 16 manufacturers reported payments, led by BD at 25.2% of the total. Reporting peaked in 2019 at $14,891 and has fallen 77.9% since, to $3,294 in 2025. Among surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 55 payments — averaging $664.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- BD$9K
- Bard Peripheral Vascular, Inc.$8K
- AstraZeneca$7K
- Guerbet LLC$5K
- Genentech, Inc.$4K
- Boston Scientific$1K
- plus $3K from 10 others
Across 4 payments — averaging $66,852 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Guerbet LLC$267K
What the payments were for
- Consulting fees$23,15263%
- Speaking & faculty fees$3381%
- Travel & lodging$8,60924%
- Food & beverage$4,47412%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| BD | 6 | $9,233 |
| Bard Peripheral Vascular, Inc. | 2 | $7,863 |
| AstraZeneca | 3 | $6,530 |
| Guerbet LLC | 15 | $4,696 |
| Genentech, Inc. | 2 | $3,909 |
| Boston Scientific | 12 | $1,086 |
| Histosonics, Inc. | 2 | $886 |
| Medtronic | 3 | $828 |
| Terumo Medical Corporation | 1 | $350 |
| Argon Medical Devices, Inc. | 1 | $338 |
| Trisalus Life Sciences, Inc. | 3 | $271 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $245 |
| BTG International Canada Inc. | 1 | $154 |
| Amgen | 1 | $125 |
| Abbott | 1 | $40 |
| Sirtex Medical Inc | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IMFINZI$6,530
- Lipiodol$4,696
- Avastin$3,909
- TECENTRIQ$3,909
- OBSIDIO$437
- Navicross$350
- Clot Management$338
- TRINAV INFUSION SYSTEM$254
- THERASPHERE-BIO$154
- EKOSONIC$149
- KRYSTEXXA$125
- TheraSphere Y90 Glass Microspheres 10 GBq$103
How this compares
$36,572 in reported general payments places this provider in the 95th percentile of 1,424 surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgery in Philadelphia
- Brett ChatmanPhiladelphia$178K
- David WernsingPhiladelphia$142K
- Said AzouryPhiladelphia$131K
- James MarkmannPhiladelphia$97K
- Daniel HewittPhiladelphia$89K
- Daniel HashimotoPhiladelphia$73K
- Scott KozinPhiladelphia$59K
- Prashanth PalvannanPhiladelphia$54K
- Henry HirschPhiladelphia$53K
- Erica PettkePhiladelphia$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.